Search

CryoPort Inc

Closed

SectorIndustrials

16.28 3.76

Overview

Share price change

24h

Current

Min

15.6

Max

16.46

Key metrics

By Trading Economics

Income

14M

-9.4M

Sales

2.3M

48M

EPS

-0.19

Profit margin

-19.733

Employees

684

EBITDA

1.2M

-2.5M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

-5.6% downside

Dividends

By Acuity

Next Earnings

4 Aug 2026

Market Stats

By TradingEconomics

Market Cap

294M

815M

Previous open

12.52

Previous close

16.28

News Sentiment

By Acuity

34%

66%

125 / 403 Industrials

CryoPort Inc Chart

Past performance is not a reliable indicator of future results.

Related News

20 Jul 2026, 21:01 UTC

Cryoport Inc shares are lower in after-market hours, reflecting broader economic concerns following a decline in the Conference Board's Leading Economic Index for June.

Peer Comparison

Price change

CryoPort Inc Forecast

Price Target

By TipRanks

-5.6% downside

12 Months Forecast

Average 14.83 USD  -5.6%

High 17 USD

Low 12 USD

Based on 7 Wall Street analysts offering 12 month price targets forCryoPort Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

7 ratings

6

Buy

1

Hold

0

Sell

Sentiment

By Acuity

125 / 403 Industrials

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About CryoPort Inc

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.
help-icon Live chat